QQQ   293.41 (-0.41%)
AAPL   141.83 (-1.70%)
MSFT   246.96 (-0.34%)
META   148.88 (-0.06%)
GOOGL   98.04 (-0.81%)
AMZN   101.88 (-1.21%)
TSLA   172.72 (-0.29%)
NVDA   199.99 (+2.36%)
NIO   11.69 (-3.15%)
BABA   110.78 (+0.53%)
AMD   81.11 (+7.93%)
T   20.33 (-0.20%)
MU   61.23 (+1.54%)
F   13.60 (+0.67%)
CGC   2.97 (-1.98%)
GE   81.08 (+0.75%)
DIS   107.89 (-0.55%)
AMC   5.34 (-0.19%)
PFE   43.85 (-0.70%)
PYPL   80.64 (-1.04%)
NFLX   356.14 (+0.64%)
QQQ   293.41 (-0.41%)
AAPL   141.83 (-1.70%)
MSFT   246.96 (-0.34%)
META   148.88 (-0.06%)
GOOGL   98.04 (-0.81%)
AMZN   101.88 (-1.21%)
TSLA   172.72 (-0.29%)
NVDA   199.99 (+2.36%)
NIO   11.69 (-3.15%)
BABA   110.78 (+0.53%)
AMD   81.11 (+7.93%)
T   20.33 (-0.20%)
MU   61.23 (+1.54%)
F   13.60 (+0.67%)
CGC   2.97 (-1.98%)
GE   81.08 (+0.75%)
DIS   107.89 (-0.55%)
AMC   5.34 (-0.19%)
PFE   43.85 (-0.70%)
PYPL   80.64 (-1.04%)
NFLX   356.14 (+0.64%)
QQQ   293.41 (-0.41%)
AAPL   141.83 (-1.70%)
MSFT   246.96 (-0.34%)
META   148.88 (-0.06%)
GOOGL   98.04 (-0.81%)
AMZN   101.88 (-1.21%)
TSLA   172.72 (-0.29%)
NVDA   199.99 (+2.36%)
NIO   11.69 (-3.15%)
BABA   110.78 (+0.53%)
AMD   81.11 (+7.93%)
T   20.33 (-0.20%)
MU   61.23 (+1.54%)
F   13.60 (+0.67%)
CGC   2.97 (-1.98%)
GE   81.08 (+0.75%)
DIS   107.89 (-0.55%)
AMC   5.34 (-0.19%)
PFE   43.85 (-0.70%)
PYPL   80.64 (-1.04%)
NFLX   356.14 (+0.64%)
QQQ   293.41 (-0.41%)
AAPL   141.83 (-1.70%)
MSFT   246.96 (-0.34%)
META   148.88 (-0.06%)
GOOGL   98.04 (-0.81%)
AMZN   101.88 (-1.21%)
TSLA   172.72 (-0.29%)
NVDA   199.99 (+2.36%)
NIO   11.69 (-3.15%)
BABA   110.78 (+0.53%)
AMD   81.11 (+7.93%)
T   20.33 (-0.20%)
MU   61.23 (+1.54%)
F   13.60 (+0.67%)
CGC   2.97 (-1.98%)
GE   81.08 (+0.75%)
DIS   107.89 (-0.55%)
AMC   5.34 (-0.19%)
PFE   43.85 (-0.70%)
PYPL   80.64 (-1.04%)
NFLX   356.14 (+0.64%)
NASDAQ:PAHC

Phibro Animal Health - PAHC Stock Forecast, Price & News

$15.59
+0.19 (+1.23%)
(As of 02/1/2023 12:28 PM ET)
Add
Compare
Today's Range
$15.38
$15.68
50-Day Range
$12.05
$15.44
52-Week Range
$11.75
$22.16
Volume
20,353 shs
Average Volume
103,326 shs
Market Capitalization
$631.40 million
P/E Ratio
13.56
Dividend Yield
3.18%
Price Target
$18.33

Phibro Animal Health MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
18.0% Upside
$18.33 Price Target
Short Interest
Healthy
2.07% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-3.93
Upright™ Environmental Score
News Sentiment
1.04mentions of Phibro Animal Health in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
10.66%
From $1.22 to $1.35 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.39 out of 5 stars

Medical Sector

239th out of 1,053 stocks

Pharmaceutical Preparations Industry

105th out of 519 stocks


PAHC stock logo

About Phibro Animal Health (NASDAQ:PAHC) Stock

Phibro Animal Health Corp. engages in the manufacture and supply of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops and markets antibacterial, nutritional specialty products, and vaccines. The Mineral Nutrition segment consists of the formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment produces specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.

Receive PAHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Phibro Animal Health and its competitors with MarketBeat's FREE daily newsletter.

PAHC Stock News Headlines

PAHC.A - | Stock Price & Latest News | Reuters
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
Cash Holders STILL Aren't Taking Steps to Prepare
Stocks are crashing... inflation is through the roof... multiple industries are getting hit hard... Americans are fearful of what might happen to their stock portfolios right now -- and who's to blame them? But former Wall Street money manager Louis Navellier says all it takes is being on the right side of this force driving the massive divide. Take action today and watch his exclusive presentation -- absolutely free of charge -- to see how you should be prepping for this phenomenon.
Phibro (PAHC) Q1 Earnings Miss Estimates, Sales Surpass
Phibro Animal Health (PAHC) Misses Q1 Earnings Estimates
Phirbo (PAHC) Faces Rising Costs and Inflationary Pressure
PHIBRO ANIMAL HEALTH CORPORATION
See More Headlines
Receive PAHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Phibro Animal Health and its competitors with MarketBeat's FREE daily newsletter.

PAHC Company Calendar

Last Earnings
11/09/2022
Ex-Dividend for 12/21 Dividend
11/29/2022
Dividend Payable
12/21/2022
Today
2/01/2023
Next Earnings (Confirmed)
2/08/2023
Fiscal Year End
6/30/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PAHC
Employees
1,860
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$18.33
High Stock Price Forecast
$20.00
Low Stock Price Forecast
$17.00
Forecasted Upside/Downside
+17.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$49.17 million
Pretax Margin
7.10%

Debt

Sales & Book Value

Annual Sales
$942.30 million
Cash Flow
$2.21 per share
Book Value
$6.48 per share

Miscellaneous

Free Float
20,228,000
Market Cap
$631.40 million
Optionable
Optionable
Beta
0.53

Key Executives

  • Jack C. Bendheim
    Chairman, President & Chief Executive Officer
  • Larry L. Miller
    Chief Operating Officer
  • Damian Finio
    Chief Financial Officer
  • Thomas G. Dagger
    Secretary, Senior Vice President & General Counsel
  • Mona Desai
    Vice President & Controller













PAHC Stock - Frequently Asked Questions

Should I buy or sell Phibro Animal Health stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Phibro Animal Health in the last twelve months. There are currently 1 sell rating, 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" PAHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PAHC, but not buy additional shares or sell existing shares.
View PAHC analyst ratings
or view top-rated stocks.

What is Phibro Animal Health's stock price forecast for 2023?

3 Wall Street research analysts have issued twelve-month price objectives for Phibro Animal Health's shares. Their PAHC share price forecasts range from $17.00 to $20.00. On average, they predict the company's stock price to reach $18.33 in the next twelve months. This suggests a possible upside of 19.0% from the stock's current price.
View analysts price targets for PAHC
or view top-rated stocks among Wall Street analysts.

How have PAHC shares performed in 2023?

Phibro Animal Health's stock was trading at $13.41 at the beginning of the year. Since then, PAHC shares have increased by 14.8% and is now trading at $15.40.
View the best growth stocks for 2023 here
.

When is Phibro Animal Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 8th 2023.
View our PAHC earnings forecast
.

How can I listen to Phibro Animal Health's earnings call?

Phibro Animal Health will be holding an earnings conference call on Thursday, February 9th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Phibro Animal Health's earnings last quarter?

Phibro Animal Health Co. (NASDAQ:PAHC) issued its quarterly earnings results on Wednesday, November, 9th. The company reported $0.21 EPS for the quarter, missing analysts' consensus estimates of $0.26 by $0.05. The company had revenue of $232.50 million for the quarter, compared to analyst estimates of $224.19 million. Phibro Animal Health had a net margin of 4.85% and a trailing twelve-month return on equity of 19.90%.

How often does Phibro Animal Health pay dividends? What is the dividend yield for Phibro Animal Health?

Phibro Animal Health declared a quarterly dividend on Monday, November 7th. Investors of record on Wednesday, November 30th will be given a dividend of $0.12 per share on Wednesday, December 21st. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.12%. The ex-dividend date of this dividend is Tuesday, November 29th.
Read our dividend analysis for PAHC
.

Is Phibro Animal Health a good dividend stock?

Phibro Animal Health (NASDAQ:PAHC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 3.15%. The dividend payout ratio is 41.74%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, PAHC will have a dividend payout ratio of 35.56% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for PAHC.

What guidance has Phibro Animal Health issued on next quarter's earnings?

Phibro Animal Health issued an update on its FY 2023 earnings guidance on Friday, December, 9th. The company provided EPS guidance of $1.21-$1.31 for the period, compared to the consensus earnings per share estimate of $1.27. The company issued revenue guidance of $960.00M-$1.00 billion, compared to the consensus revenue estimate of $978.68 million.

What is Jack Bendheim's approval rating as Phibro Animal Health's CEO?

4 employees have rated Phibro Animal Health Chief Executive Officer Jack Bendheim on Glassdoor.com. Jack Bendheim has an approval rating of 100% among the company's employees. This puts Jack Bendheim in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Phibro Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Phibro Animal Health investors own include Zynga (ZNGA), Trevena (TRVN), Endo International (ENDP), Sonoma Pharmaceuticals (SNOA), Zynerba Pharmaceuticals (ZYNE), Intercept Pharmaceuticals (ICPT), VIVUS (VVUS), Zoetis (ZTS), Banco Bradesco (BBD) and Booking (BKNG).

What is Phibro Animal Health's stock symbol?

Phibro Animal Health trades on the NASDAQ under the ticker symbol "PAHC."

Who are Phibro Animal Health's major shareholders?

Phibro Animal Health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Bridge City Capital LLC (0.25%), Allspring Global Investments Holdings LLC (0.25%), New York State Common Retirement Fund (0.23%), Dupont Capital Management Corp (0.07%), Inspire Investing LLC (0.04%) and Diversified Trust Co (0.03%). Insiders that own company stock include E Thomas Corcoran and Larry Lee Miller.
View institutional ownership trends
.

How do I buy shares of Phibro Animal Health?

Shares of PAHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Phibro Animal Health's stock price today?

One share of PAHC stock can currently be purchased for approximately $15.40.

How much money does Phibro Animal Health make?

Phibro Animal Health (NASDAQ:PAHC) has a market capitalization of $623.70 million and generates $942.30 million in revenue each year. The company earns $49.17 million in net income (profit) each year or $1.15 on an earnings per share basis.

How many employees does Phibro Animal Health have?

The company employs 1,860 workers across the globe.

How can I contact Phibro Animal Health?

Phibro Animal Health's mailing address is GLENPOINTE CENTRE EAST 3RD FLOOR 300 FRANK W. BURR BLVD. SUITE 21, TEANECK NJ, 07666. The official website for the company is www.pahc.com. The company can be reached via phone at (201) 329-7300, via email at investor.relations@pahc.com, or via fax at 201-329-7399.

This page (NASDAQ:PAHC) was last updated on 2/1/2023 by MarketBeat.com Staff